India COVID-19 Vaccines Market to Showcase A CAGR of 25% Through 2027

February 18, 2021

According the research report titled ‘India COVID-19 Vaccines Market - Growth, Demand, Trends, Opportunity, Forecasts (2021 - 2027)’, available with Market Study Report LLC, India COVID-19 vaccines market is set to register a y-o-y growth rate of 25% over 2021-2027, subsequently accumulating USD 2.3 billion by the end of the stipulated timeframe.

As per the findings of the report, India COVID-19 vaccines market is largely driven by increasing approval/launches of new vaccines, rising government support for vaccine research & development, and growing focus on immunization programs.

Request sample copy of this Report:

In addition to the aforementioned factors, the study explicates the key challenges and opportunities shaping the market dynamics. It also offers latest industry data pertaining to current and future scenario of this vertical, together with a comprehensive estimation of the market size over the analysis period.

Proceeding further, intricate details such as number of persons inoculated, and doses administered in the Indian market are provided. The report also elaborates on the roles of various Indian ministries/departments in COVID-19 vaccine rollout and the COVID-19 vaccine intelligence network (Co-WIN).

Apart from this, the research document profiles the prominent players in Indian COVID-19 vaccines industry. These players are assessed in terms of aspects such as business overview, promising vaccines in clinical development, and COVID-19 vaccines portfolio. Additionally, it makes inclusion of the competitive developments and strategic undertakings, including collaboration & partnerships, new vaccine developing, exclusive and licensing agreements, and R&D activities

Key players profiled in India COVID-19 vaccines market report are Dr. Reddy's Laboratories Ltd., Gennova Biopharmaceuticals Ltd., Biological E. Ltd., Zydus Cadila, Serum Institute of India, Bharat Biotech International Ltd.

Chat with us